Browsing by Author "Ho, Hao"

Now showing 1 - 3 of 3
  • Thumbnail Image
    Item
    Accurate Intramyocardial Hemorrhage Assessment with Fast, Free-running, Cardiac Quantitative Susceptibility Mapping
    (Radiological Society of North America, 2024) Huang, Yuheng; Guan, Xingmin; Zhang, Xinheng; Yoosefian, Ghazal; Ho, Hao; Huang, Li-Ting; Lin, Hsin-Yao; Anthony, Gregory; Lee, Hsu-Lei; Bi, Xiaoming; Han, Fei; Chan, Shing Fai; Vora, Keyur P.; Sharif, Behzad; Singh, Dhirendra P.; Youssef, Khalid; Li, Debiao; Han, Hui; Christodoulou, Anthony G.; Dharmakumar, Rohan; Yang, Hsin-Jung; Medicine, School of Medicine
    Purpose: To evaluate the performance of a high-dynamic-range quantitative susceptibility mapping (HDR-QSM) cardiac MRI technique to detect intramyocardial hemorrhage (IMH) and quantify iron content using phantom and canine models. Materials and Methods: A free-running whole-heart HDR-QSM technique for IMH assessment was developed and evaluated in calibrated iron phantoms and 14 IMH female canine models. IMH detection and iron content quantification performance of this technique was compared with the conventional iron imaging approaches, R2*(1/T2*) maps, using measurements from ex vivo imaging as the reference standard. Results: Phantom studies confirmed HDR-QSM’s accurate iron content quantification and artifact mitigation ability by revealing a strong linear relationship between iron concentration and QSM values (R2, 0.98). In in vivo studies, HDR-QSM showed significantly improved image quality and susceptibility homogeneity in nonaffected myocardium by alleviating motion and off-resonance artifacts (HDR-QSM vs R2*: coefficient of variation, 0.31 ± 0.16 [SD] vs 0.73 ± 0.36 [P < .001]; image quality score [five-point Likert scale:], 3.58 ± 0.75 vs 2.87 ± 0.51 [P < .001]). Comparison between in vivo susceptibility maps and ex vivo measurements showed higher performance of HDR-QSM compared with R2* mapping for IMH detection (area under the receiver operating characteristic curve, 0.96 vs 0.75; P < .001) and iron content quantification (R2, 0.71 vs 0.14). Conclusion: In a canine model of IMH, the fast and free-running cardiac QSM technique accurately detected IMH and quantified intramyocardial iron content of the entire heart within 5 minutes without requiring breath holding.
  • Thumbnail Image
    Item
    Correction to: Quantification of myocardial hemorrhage using T2* cardiovascular magnetic resonance at 1.5 T with ex-vivo validation
    (Elsevier, 2022-02-07) Chen, Yinyin; Ren, Daoyuan; Guan, Xingmin; Yang, Hsin‑Jung; Liu, Ting; Tang, Richard; Ho, Hao; Jin, Hang; Zeng, Mengsu; Dharmakumar, Rohan; Radiology and Imaging Sciences, School of Medicine
    In the original publication [1] an error was introduced in the affiliations of Yinyin Chen due to a misunderstanding during the publication process. The incorrect and correct affiliations are listed below. The original article has been updated.
  • Thumbnail Image
    Item
    Quantification of myocardial hemorrhage using T2* cardiovascular magnetic resonance at 1.5T with ex-vivo validation
    (Elsevier, 2021-09-30) Chen, Yinyin; Ren, Daoyuan; Guan, Xingmin; Yang, Hsin‑Jung; Liu, Ting; Tang, Richard; Ho, Hao; Jin, Hang; Zeng, Mengsu; Dharmakumar, Rohan; Radiology and Imaging Sciences, School of Medicine
    Background: T2* cardiovascular magnetic resonance (CMR) is commonly used in the diagnosis of intramyocardial hemorrhage (IMH). For quantifying IMH with T2* CMR, despite the lack of consensus studies, two different methods [subject-specific T2* (ssT2*) and absolute T2* thresholding (aT2* < 20 ms)] are interchangeably used. We examined whether these approaches yield equivalent information. Methods: ST elevation myocardial infarction (STEMI) patients (n = 70) were prospectively recruited for CMR at 4-7 days post revascularization and for 6-month follow up (n = 43). Canines studies were performed for validation purposes, where animals (n = 20) were subject to reperfused myocardial infarction (MI) and those surviving the MI (n = 16) underwent CMR at 7 days and 8 weeks and then euthanized. Both in patients and animals, T2* of IMH and volume of IMH were determined using ssT2* and aT2* < 20 ms. In animals, ex-vivo T2* CMR and mass spectrometry for iron concentration ([Fe]Hemo) were determined on excised myocardial sections. T2* values based on ssT2* and absolute T2* threshold approaches were independently regressed against [Fe]Hemo and compared. A range of T2* cut-offs were tested to determine the optimized conditions relative to ssT2*. Results: While both approaches showed many similarities, there were also differences. Compared to ssT2*, aT2* < 20 ms showed lower T2* and volume of IMH in patients and animals independent of MI age (all p < 0.005). While T2* determined from both methods were highly correlated against [Fe]Hemo (R2 = 0.9 for both), the slope of the regression curve for ssT2* was significantly larger as compared to aT2* < 20 ms (0.46 vs. 0.32, p < 0.01). Further, slightly larger absolute T2* cut-offs (patients: 23 ms; animals: 25 ms) showed similar IMH characteristics compared to ssT2*. Conclusion: Current quantification methods have excellent capacity to identify IMH, albeit the T2*of IMH and volume of IMH based on aT2* < 20 ms are smaller compared to ssT2*. Thus the method used to quantify IMH from T2* CMR may influence the diagnosis for IMH.